Skip to content
1st Counsel – Lifestyle
Author:
Deck Bio, Inc. / Russo Partners, LLC.
Deck Bio Presents Preclinical Data on DBXO-1, a Multi-pMHC Targeted T Cell Engager, at AACR 2026
April 20, 2026
Deck Bio Launches Multi-Target T Cell Engager Platform for Solid Tumors, With Preclinical Data to be Presented at AACR 2026
April 9, 2026